Fiegl M - Search Results

1

Incidental Diagnosis of Asymptomatic Non-Small-Cell Lung Cancer: A Registry-Based Analysis.

Kocher F, Lunger F, Seeber A, Amann A, Pircher A, Hilbe W, Fiegl M. Kocher F, et al. Among authors: fiegl m. Clin Lung Cancer. 2016 Jan;17(1):62-7.e1. doi: 10.1016/j.cllc.2015.08.006. Epub 2015 Aug 22. Clin Lung Cancer. 2016. PMID: 26420370

2

Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer.

Pircher A, Ulsperger E, Hack R, Jamnig H, Pall G, Zelger B, Sterlacci W, Hilbe W, Fiegl M. Pircher A, et al. Among authors: fiegl m. Anticancer Res. 2011 Sep;31(9):2949-55. Anticancer Res. 2011. PMID: 21868543

3

Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs).

Pircher A, Fiegl M, Untergasser G, Heidegger I, Medinger M, Kern J, Hilbe W. Pircher A, et al. Among authors: fiegl m. Lung Cancer. 2013 Aug;81(2):252-8. doi: 10.1016/j.lungcan.2013.04.014. Epub 2013 May 10. Lung Cancer. 2013. PMID: 23664449

4

Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement.

Pircher A, Wasle IK, Mian M, Gamerith G, Ulsperger E, Studnicka M, Mohn-Staudner A, Hilbe W, Fiegl M. Pircher A, et al. Among authors: fiegl m. Anticancer Res. 2013 Sep;33(9):3831-6. Anticancer Res. 2013. PMID: 24023316

5

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

Kocher F, Hilbe W, Seeber A, Pircher A, Schmid T, Greil R, Auberger J, Nevinny-Stickel M, Sterlacci W, Tzankov A, Jamnig H, Kohler K, Zabernigg A, Frötscher J, Oberaigner W, Fiegl M. Kocher F, et al. Among authors: fiegl m. Lung Cancer. 2015 Feb;87(2):193-200. doi: 10.1016/j.lungcan.2014.12.006. Epub 2014 Dec 18. Lung Cancer. 2015. PMID: 25564398

6

Cardiovascular Comorbidities and Events in NSCLC: Often Underestimated but Worth Considering.

Kocher F, Fiegl M, Mian M, Hilbe W. Kocher F, et al. Among authors: fiegl m. Clin Lung Cancer. 2015 Jul;16(4):305-12. doi: 10.1016/j.cllc.2014.12.007. Epub 2014 Dec 30. Clin Lung Cancer. 2015. PMID: 25659438

7

Liver Transplantation-Associated Lung Cancer: Comparison of Clinical Parameters and Outcomes.

Kocher F, Finkenstedt A, Fiegl M, Graziadei I, Gamerith G, Oberaigner W, Vogel W, Hilbe W. Kocher F, et al. Among authors: fiegl m. Clin Lung Cancer. 2015 Sep;16(5):e75-81. doi: 10.1016/j.cllc.2015.02.003. Epub 2015 Feb 17. Clin Lung Cancer. 2015. PMID: 25783479

8

NSCLC without Antineoplastic Treatment: Incidence, Characteristics, and Outcome as Outlined in the TYROL Study.

Kocher F, Lunger F, Pircher A, Hilbe W, Fiegl M. Kocher F, et al. Among authors: fiegl m. Oncology. 2015;89(5):255-61. doi: 10.1159/000433544. Epub 2015 Aug 18. Oncology. 2015. PMID: 26303584

9

Reply.

Kocher F, Lunger F, Seeber A, Amann A, Pircher A, Hilbe W, Fiegl M. Kocher F, et al. Among authors: fiegl m. Clin Lung Cancer. 2016 Sep;17(5):e187. doi: 10.1016/j.cllc.2016.04.008. Epub 2016 May 7. Clin Lung Cancer. 2016. PMID: 27245293 No abstract available.

10

Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patient.

Pircher A, Manzl C, Fiegl M, Popper H, Pirker R, Hilbe W. Pircher A, et al. Among authors: fiegl m. Lung Cancer. 2014 Mar;83(3):408-10. doi: 10.1016/j.lungcan.2013.12.007. Epub 2013 Dec 25. Lung Cancer. 2014. PMID: 24412619

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters